Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | MARK3 | P27448 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.30 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.30 |
| ▸ | ITGAL | P20701 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19797352 | 0.97 | EGLN1 (0.33) | EGLN1LMNAHTTKMT2AMEN1 | |
| SCHEMBL19797397 | 0.92 | — | — | |
| SCHEMBL19797395 | 0.87 | PGR (0.36) | EGLN1PGR | |
| SCHEMBL19797396 | 0.87 | — | — | |
| SCHEMBL19797390 | 0.82 | TNKS (0.36) | EGLN1 | |
| SCHEMBL13231589 | 0.82 | LMNA (0.39) | LMNAHTTKMT2AMEN1MAPT | |
| SCHEMBL19797355 | 0.82 | EGLN1 (0.34) | EGLN1LMNAHTTKMT2AMEN1 | |
| SCHEMBL19797414 | 0.81 | ITGB2 (0.33) | EGLN1LMNAHTTKMT2AMEN1 | |
| SCHEMBL19797364 | 0.80 | NPSR1 (0.33) | LMNAHTTKMT2AMEN1MAPT | |
| SCHEMBL22639689 | 0.79 | PGR (0.32) | MARK3PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10388889-B2 | Substituted phosphines as components of organic light-emitting devices | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-08-20 | — | — | US | disclosed |
| US-20180026206-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
| US-20180026206-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180026206-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CYP1A1, CYP1B1 | EGLN1 2290/4885LMNA 2798/4885HTT 2064/4885 |
| US-10388889-B2 | Substituted phosphines as components of organic light-emitting devices | CRY1, CRY2, PER2 | EGLN1 4390/4885LMNA 3701/4885HTT 3907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.